SACKSTEIN; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for SACKSTEIN; Robert.The latest application filed is for "fucosyltransferase specific inhibition using fucose mimetics".

Company Profile

7.27.51

SACKSTEIN; Robert - Miami FL
Sackstein; Robert - Pinecrest FL
Sackstein; Robert - US
SACKSTEIN; Robert - Sudbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fucosyltransferase Specific Inhibition Using Fucose Mimetics App 20220211734 - SACKSTEIN; Robert ; et al.	2022-07-07
Compositions And Methods For Production Of Exofucosylated Cells For Clinical Applications App 20210123024 - Sackstein; Robert	2021-04-29
Compositions And Methods For Modifying Cell Surface Glycans App 20210087541 - SACKSTEIN; Robert	2021-03-25
Compositions And Methods For Enforcing Fucosylation Of Lactosaminyl Glycans In Human Cells With Alpha(1,3)-fucosyltransferases App 20210017562 - SACKSTEIN; ROBERT	2021-01-21
Methods To Improve Cell Therapy App 20200281985 - SACKSTEIN; Robert	2020-09-10
Methods to improve cell therapy Grant 10,471,103 - Sackstein Nov	2019-11-12
Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor App 20190246629 - Liu; Qiyong Peter ; et al.	2019-08-15
Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectin Grant 10,370,642 - Sackstein	2019-08-06
Glycoengineering Of E-selectin Ligands App 20190201444 - Sackstein; Robert	2019-07-04
Platelet Additive Solution Having a Beta-Galactosidase Inhibitor App 20190200602 - Liu; Qiyong Peter ; et al.	2019-07-04
Platelet additive solution having a beta-galactosidase inhibitor Grant 10,271,541 - Liu , et al.	2019-04-30
Compositions And Methods For Modifying Cell Surface Glycans App 20180127731 - SACKSTEIN; Robert	2018-05-10
Compositions and methods for modifying cell surface glycans Grant 9,914,913 - Sackstein March 13, 2	2018-03-13
Platelet Protection Solution Having Beta-Galactosidase and Sialidase Inhibitors App 20180000066 - Liu; Qiyong Peter ; et al.	2018-01-04
Platelet protection solution having beta-galactosidase and sialidase inhibitors Grant 9,788,539 - Liu , et al. October 17, 2	2017-10-17
Platelet Additive Solution Having a beta-Galactosidase Inhibitor App 20170156310 - Liu; Qiyong Peter ; et al.	2017-06-08
Platelet additive solution having a .beta.-galactosidase inhibitor Grant 9,609,861 - Liu , et al. April 4, 2	2017-04-04
Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptide Grant 9,523,078 - Sackstein December 20, 2	2016-12-20
Hematopoietic Cell E-selectin/l-selectin Ligand Polypeptides And Methods Of Use Thereof App 20160201033 - SACKSTEIN; Robert	2016-07-14
Hematopoietic Cell Selectin Ligand Polypeptides And Methods Of Use Thereof App 20160194376 - SACKSTEIN; Robert	2016-07-07
Methods To Improve Cell Therapy App 20160184367 - SACKSTEIN; Robert	2016-06-30
Platelet Additive Solution Having a beta-Galactosidase Inhibitor App 20160174543 - Liu; Qiyong Peter ; et al.	2016-06-23
Platelet Protection Solution Having Beta-Galactosidase and Sialidase Inhibitors App 20160143269 - Liu; Qiyong Peter ; et al.	2016-05-26
Platelet Storage and Reduced Bacterial Proliferation in Platelet Products Using a Sialidase Inhibitor App 20160000064 - Liu; Qiyong Peter ; et al.	2016-01-07
Compositions And Methods For Modifying Cell Surface Glycans App 20150259654 - SACKSTEIN; Robert	2015-09-17
Compositions and methods for modifying cell surface glycans Grant 8,852,935 - Sackstein October 7, 2	2014-10-07
Methods Of Treating Complications And Disorders Associated With G-csf Administration App 20140199316 - SACKSTEIN; Robert	2014-07-17
Methods of treating complications and disorders associated with G-CSF administration Grant 8,765,126 - Sackstein July 1, 2	2014-07-01
Cytokine Induction Of Selectin Ligands On Cells App 20140170120 - SACKSTEIN; Robert	2014-06-19
Methods for modifying cell surface glycans Grant 8,728,810 - Sackstein May 20, 2	2014-05-20
Platelet Additive Solution Having a beta-Galactosidase Inhibitor App 20140099629 - Liu; Qiyong Peter ; et al.	2014-04-10
Cytokine induction of selectin ligands on cells Grant 8,633,026 - Sackstein January 21, 2	2014-01-21
Methods Of Treating Complications And Disorders Associated With G-csf Administration App 20130224217 - SACKSTEIN; Robert	2013-08-29
Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof App 20130089927 - Sackstein; Robert	2013-04-11
Hematopoietic Cell Selectin Ligand Polypeptides And Methods Of Use Thereof App 20130058959 - Sackstein; Robert	2013-03-07
Hematopoietic Cell Selectin Ligand Polypeptides And Methods Of Use Thereof App 20130059333 - Sackstein; Robert	2013-03-07
Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor App 20120321601 - Liu; Qiyong Peter ; et al.	2012-12-20
Compositions And Methods For Modifying Cell Surface Glycans App 20120107281 - Sackstein; Robert	2012-05-03
Compositions And Methods For Modifying Cell Surface Glycans App 20120107924 - Sackstein; Robert	2012-05-03
Compositions and methods for modifying cell surface glycans Grant 8,084,236 - Sackstein December 27, 2	2011-12-27
Cytokine induction of selectin ligands on cells Grant 7,998,740 - Sackstein August 16, 2	2011-08-16
Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide App 20110189139 - Sackstein; Robert	2011-08-04
Cytokine Induction Of Selectin Ligands On Cells App 20110177040 - SACKSTEIN; ROBERT	2011-07-21
Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide Grant 7,875,585 - Sackstein January 25, 2	2011-01-25
Antibody SACK-1 that binds CD44 glycoforms Grant 7,816,500 - Sackstein October 19, 2	2010-10-19
Compositions and Methods for Modifying Cell Surface Glycans App 20090239296 - Sackstein; Robert	2009-09-24
Cytokine Induction of Selectin Ligands on Cells App 20090053198 - Sackstein; Robert	2009-02-26
Compositions and methods for modifying cell surface glycans App 20080044383 - Sackstein; Robert	2008-02-21
Fluorinated glucosamine analogs useful for modulating post-translational glyscosylations on cells App 20060281708 - Sackstein; Robert ; et al.	2006-12-14
Hematopoietic cell selectin ligand polypeptides and methods of use thereof App 20060210558 - Sackstein; Robert	2006-09-21
Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells Grant 7,098,195 - Sackstein , et al. August 29, 2	2006-08-29
Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereof App 20060003924 - Sackstein; Robert	2006-01-05
Antibodies to CD44 glycoforms and uses thereof App 20050214283 - Sackstein, Robert	2005-09-29
Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells App 20030148997 - Sackstein, Robert ; et al.	2003-08-07
Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof App 20030040607 - Sackstein, Robert	2003-02-27

Company Registrations

NCAGE Code	43Z76	SACKSTEIN ROBERT
CAGE Code	43Z76	SACKSTEIN, ROBERT
DUNS	603837449	SACKSTEIN, ROBERT

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.